Just days before presenting at ASH conference, Syndax outlines plan to raise $150M
Syndax is banking that upcoming clinical data will be enough to woo investors — to the tune of $150 million.
The biotech kept it short in …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
